IL110812A0 - Phenylalkanolamine derivatives, their preparation and pharmaceutical compositions containing them - Google Patents

Phenylalkanolamine derivatives, their preparation and pharmaceutical compositions containing them

Info

Publication number
IL110812A0
IL110812A0 IL11081294A IL11081294A IL110812A0 IL 110812 A0 IL110812 A0 IL 110812A0 IL 11081294 A IL11081294 A IL 11081294A IL 11081294 A IL11081294 A IL 11081294A IL 110812 A0 IL110812 A0 IL 110812A0
Authority
IL
Israel
Prior art keywords
hydrogen
hydroxy
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL11081294A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL110812A0 publication Critical patent/IL110812A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Solid Fuels And Fuel-Associated Substances (AREA)
  • Fats And Perfumes (AREA)
  • Organic Insulating Materials (AREA)
  • Table Devices Or Equipment (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Indole Compounds (AREA)
IL11081294A 1993-09-02 1994-08-29 Phenylalkanolamine derivatives, their preparation and pharmaceutical compositions containing them IL110812A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11638593A 1993-09-02 1993-09-02

Publications (1)

Publication Number Publication Date
IL110812A0 true IL110812A0 (en) 1994-11-11

Family

ID=22366865

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11081294A IL110812A0 (en) 1993-09-02 1994-08-29 Phenylalkanolamine derivatives, their preparation and pharmaceutical compositions containing them

Country Status (22)

Country Link
EP (1) EP0648744B1 (xx)
JP (1) JP2610784B2 (xx)
KR (1) KR100360954B1 (xx)
CN (1) CN1061035C (xx)
AT (1) ATE162520T1 (xx)
AU (1) AU7149794A (xx)
BR (1) BR9403418A (xx)
CA (1) CA2129771C (xx)
CZ (1) CZ210694A3 (xx)
DE (1) DE69408078T2 (xx)
DK (1) DK0648744T3 (xx)
ES (1) ES2113585T3 (xx)
FI (1) FI107607B (xx)
GR (1) GR3026622T3 (xx)
HU (1) HUT70558A (xx)
IL (1) IL110812A0 (xx)
NO (1) NO943231L (xx)
NZ (1) NZ264320A (xx)
PL (1) PL304863A1 (xx)
RU (1) RU94031753A (xx)
TW (1) TW281670B (xx)
ZA (1) ZA946529B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214994B1 (en) 1997-04-21 2001-04-10 Molecular Geriatrics Corporation Certain substituted 1-aryl-3-piperazin-1′-yl propanones
US5658909A (en) 1994-11-17 1997-08-19 Molecular Geriatrics Corporation Certain substituted 1-aryl-3-piperazin-1'-yl propanones to treat Alzheimer's Disease
US5693804A (en) * 1994-11-17 1997-12-02 Molecular Geriatrics Corporation Substituted 1-aryl-3-piperazin-1'-yl propanones
FR2742051B1 (fr) * 1995-12-06 1998-02-06 Synthelabo Utilisation de composes ayant une affinite pour le site de liaison du (3h)ifenprodil pour la fabrication de medicaments utiles dans la prevention et le traitement des neuropathies
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610736B (en) * 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
TW498067B (en) * 1996-07-19 2002-08-11 Hoffmann La Roche 4-hydroxy-piperidine derivatives
IL134363A0 (en) 1997-10-24 2001-04-30 Warner Lambert Co Method for treating disease-related or drug-induced dyskinesias
GB9804885D0 (en) 1998-03-06 1998-04-29 Merck Sharp & Dohme Therapeutic combination
DE19812331A1 (de) 1998-03-20 1999-09-23 Merck Patent Gmbh Piperidinderivate
IL159393A (en) 2001-07-24 2011-01-31 Richter Gedeon Vegyeszet Piperidine derivatives, pharmaceutical compositions containing them, processes for their preparation and uses thereof
WO2005030720A1 (ja) 2003-09-25 2005-04-07 Shionogi & Co., Ltd. Nmda受容体拮抗作用を有するピペリジン誘導体
RU2638807C2 (ru) 2011-11-22 2017-12-15 Те Риджентс Оф Те Юниверсити Оф Калифорния Способы и композиции для лечения воспаления и ишемического поражения
RU2649406C1 (ru) * 2017-09-21 2018-04-03 Федеральное государственное бюджетное учреждение науки Новосибирский институт органической химии им. Н.Н. Ворожцова Сибирского отделения Российской академии наук (НИОХ СО РАН) 3-n-замещенные борнилпропионаты, используемые в качестве ингибиторов вируса марбург

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4261285A (en) * 1984-06-01 1985-12-05 Tokyo Tanabe Company Limited 1-propanone derivatives
DE3433036A1 (de) * 1984-09-08 1986-03-20 Basf Ag, 6700 Ludwigshafen Piperidinderivate und diese enthaltende fungizide sowie verfahren zur bekaempfung von pilzen
EP0398578B1 (en) * 1989-05-17 1997-03-12 Pfizer Inc. 2-piperidino-1-alkanol derivatives as antiischemic agents
US4940789A (en) * 1989-10-10 1990-07-10 American Home Products Corporation 10,11-dihydro-5-alkyl-12-substituted-10,5-(iminomethano)-5H-dibenzo[a,d]cycloheptenes as neuroprotectant agents
EP0553278B1 (en) * 1990-10-15 1997-06-04 Astra Aktiebolag 2-phenyl-and 2-thienyl-(2)-piperidine derivatives having neuroprotective properties
SE9003652D0 (sv) * 1990-11-15 1990-11-15 Astra Ab New heterocyclic compounds

Also Published As

Publication number Publication date
FI944044A0 (fi) 1994-09-02
HUT70558A (en) 1995-10-30
JP2610784B2 (ja) 1997-05-14
KR950008481A (ko) 1995-04-17
DE69408078T2 (de) 1998-07-09
BR9403418A (pt) 1996-09-03
DK0648744T3 (da) 1998-09-21
CA2129771C (en) 2006-03-21
ZA946529B (en) 1995-03-02
GR3026622T3 (en) 1998-07-31
PL304863A1 (en) 1995-03-06
ATE162520T1 (de) 1998-02-15
KR100360954B1 (ko) 2003-04-16
NO943231D0 (no) 1994-09-01
CN1105990A (zh) 1995-08-02
CA2129771A1 (en) 1995-03-03
FI944044A (fi) 1995-03-03
AU7149794A (en) 1995-03-16
TW281670B (xx) 1996-07-21
NO943231L (no) 1995-03-03
CZ210694A3 (en) 1995-08-16
FI107607B (fi) 2001-09-14
EP0648744A1 (en) 1995-04-19
ES2113585T3 (es) 1998-05-01
JPH0782250A (ja) 1995-03-28
EP0648744B1 (en) 1998-01-21
DE69408078D1 (de) 1998-02-26
RU94031753A (ru) 1996-07-20
CN1061035C (zh) 2001-01-24
HU9402479D0 (en) 1994-10-28
NZ264320A (en) 1996-02-27

Similar Documents

Publication Publication Date Title
IL110812A0 (en) Phenylalkanolamine derivatives, their preparation and pharmaceutical compositions containing them
IL110151A0 (en) Amide and urea derivatives and pharmaceutical compositions containing the same
GR3018212T3 (en) Naphtylalkylamines, process for their preparation and pharmaceutical compositions containing them.
EP0389282A3 (en) Xanthinederivatives, process for their preparation and their pharmaceutical use
GB8826595D0 (en) Active compounds
IL114785A0 (en) Pyrrolocarbazoles their preparation and pharmaceutical compositions containing them
HUT70548A (en) Oxazolidone derivatives, process for producing them and pharmaceutical compositions containing them
HUT54362A (en) Process for producing cumarin derivatives and pharmaceutical compositions containing them
GR3007401T3 (xx)
GR3017599T3 (en) Thiochromane derivatives, process for their preparation and pharmaceutical compositions containing them.
IL89942A (en) Heterotetracyclic lactam derivatives, their preparation and pharmaceutical compositions containing them
HUT66623A (en) Process for preparing methanoanthracene derivatives and pharmaceutical compositions contg. them as active ingredient
GR3007219T3 (xx)
AU657423B2 (en) Novel piperidine derivatives and process for preparation thereof
HU904013D0 (en) Process for producing substituted 3-amino-sydnonimine derivatives and pharmaceutical preparatives containing these